🔗 Visit the ClinicalTrials.gov page for NCT00354263
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Lymphocyte activation gene-3 (LAG-3, CD223) in plasmacytoid dendritic cells (pDCs): a molecular target for the restoration of active antitumor immunity. | Oncoimmunology | 2014 | 0.81 |
| 2 | Lymphocyte-activation gene-3, an important immune checkpoint in cancer. | Cancer Sci | 2016 | 0.76 |